Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 42 publications
Acute pancreatitis risk in type 2 diabetes patients treated with canagliflozin versus other antihyperglycemic agents: an observational claims database study.
Journal: Current medical research and opinion
Published: April 28, 2020
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy.
Journal: The New England journal of medicine
Published: April 17, 2019
Diabetic ketoacidosis in patients with type 2 diabetes treated with sodium glucose co-transporter 2 inhibitors versus other antihyperglycemic agents: An observational study of four US administrative claims databases.
Journal: Pharmacoepidemiology and drug safety
Published: March 26, 2019
Factors influencing longitudinal changes of circulating liver enzyme concentrations in subjects randomized to placebo in four clinical trials.
Journal: American journal of physiology. Gastrointestinal and liver physiology
Published: November 30, 2018
Achieving the composite endpoint of HbA1c, body weight, and systolic blood pressure reduction with canagliflozin in patients with type 2 diabetes.
Journal: Current medical research and opinion
Published: October 13, 2017
Longer-term safety and tolerability of canagliflozin in patients with type 2 diabetes: a pooled analysis.
Journal: Current medical research and opinion
Published: December 16, 2016
Rationale, design and baseline characteristics of the CANagliflozin cardioVascular Assessment Study-Renal (CANVAS-R): A randomized, placebo-controlled trial.
Journal: Diabetes, obesity & metabolism
Published: October 31, 2016
Canagliflozin: Efficacy and Safety in Combination with Metformin Alone or with Other Antihyperglycemic Agents in Type 2 Diabetes.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: August 01, 2016
Efficacy and safety of canagliflozin in patients with type 2 diabetes mellitus from India.
Journal: Indian journal of endocrinology and metabolism
Published: May 18, 2016
Efficacy and Safety of Canagliflozin in Type 2 Diabetes Patients of Different Ethnicity.
Journal: Ethnicity & disease
Published: April 23, 2016
Effects of canagliflozin on body weight and body composition in patients with type 2 diabetes over 104 weeks.
Journal: Postgraduate medicine
Published: March 23, 2016
Efficacy and Safety of Canagliflozin in Individuals Aged 75 and Older with Type 2 Diabetes Mellitus: A Pooled Analysis.
Journal: Journal of the American Geriatrics Society
Published: March 23, 2016
Last Updated: 09/26/2026